ESMO 2022 Conference Coverage
N

ESMO 2022 on the DAISY Trial: Antitumor Activity of T-DXd in Patients With mBC and Brain Metastases

By ESMO 2022 Conference Coverage FEATURING Nicolas Epaillard
September 14, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

09:04
Lilly Migraine

Examining the Safety Profile of a Preventive Treatment for Migraine

Feat. J. Ailani

Featured Video

08:52
Lilly Migraine

A Discussion of a Population-Based Study and Its Implications for Mi…

Feat. D. Buse, R. Lipton

Related Content

AUTOPLAY
27:39
Breast Health Global Initiative

Metastatic Breast Disease: Treatment and Palliative Care

Feat. A. Eniu
14:37
Cleveland Clinic Taussig Cancer Institute

Hormone Receptor-Postive Advanced Breast Cancer Case 2: Patient with…

Feat. J. Abraham
30:13
Nico Karssemeijer

Deep Learning Systems for Reading Mammograms and Breast Tomosynthesis

19:43
Northwestern Medicine: Chicago Live

Northwestern Live: Live Case - 47 y/o Female with History of Metasta…

Feat. D. Mullady, A. Aadam
17:54
Heather McArthur

Modern Immune Therapy in ER, HR+/HER2-, HER2+ Breast Cancer

19:23
Holy Cross 9th Annual Winter Oncology Symposium

Genetic Testing in Breast and Ovarian Cancer: BRCA1/2 and PARP Inhib…

Feat. D. Guaqueta
24:03
Holy Cross 9th Annual Winter Oncology Symposium

Early Stage Breast Cancer - Comparison of Trials of Genomic Assays -…

Feat. R. L. Mahtani
13:07
Holy Cross 9th Annual Winter Oncology Symposium

Panel Discussion on Breast Cancer: Promising Drugs and Future Treatm…

Feat. E. Segota, R. L. Mahtani, J. Burgers, M. Abu-Khalaf, B. Moy
07:43
Dana-Farber Cancer Institute

Study of Abemaciclib for Patients with RB-Positive, Triple Negative …

Feat. S. Goel
24:33
Holy Cross 9th Annual Winter Oncology Symposium

Therapeutic Strategies in HER2+ Breast Cancer - Pertuzumab, Neratini…

Feat. B. Moy
12:05
Holy Cross 9th Annual Winter Oncology Symposium

Future Directions in the Targeting of HER2+ Breast Cancer: duration …

Feat. B. Moy
12:44
Holy Cross 9th Annual Winter Oncology Symposium

Emerging Targets in ER Positive Breast Cancer: CDK4/6 inhibitors, Bc…

Feat. M. Abu-Khalaf
07:31
Weill Cornell Medicine Courses and Meetings

Available Prognostic Indices for Patients with Brain Metastases: RTO…

Feat. P. Sperduto
14:41
Weill Cornell Medicine Courses and Meetings

New Approaches to Estimating Prognosis for Patients with Brain Metas…

Feat. P. Sperduto
13:27
Weill Cornell Medicine Courses and Meetings

Current and Future Options in Preoperative and Postoperative Imaging…

Feat. G. Chiang
13:21
Weill Cornell Medicine Courses and Meetings

The Role of Precision Medicine in Brain Metastases: Systemic Targete…

Feat. J. Cohen
16:03
Weill Cornell Medicine Courses and Meetings

Outcomes of Targeted Therapy in EGFR and ALK-Positive NSCLC Brain Me…

Feat. M. Ahluwalia
08:26
Weill Cornell Medicine Courses and Meetings

Outcomes of Immunotherapy in NSCLC Brain Metastases: The Impact of S…

Feat. M. Ahluwalia
21:04
Weill Cornell Medicine Courses and Meetings

The Changing Landscape of Chemo, Molecular Targeted, and Immuno Syst…

Feat. A. Morikawa
14:10
Weill Cornell Medicine Courses and Meetings

Systemic Therapy for Melanoma Brain Metastases: RAF/MEK Inhibitors a…

Feat. P. Chapman